ArticleBMC rheumatology2026
The associations between age, familial occurrence of fibromyalgia, and symptom severity in fibromyalgia: a cross-sectional study from a Finnish health center.
Article in BMC rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFibromyalgia is a functional syndrome characterized by musculoskeletal pain and a variety of associated symptoms. Previous research has shown that close relatives are at a higher risk of developing the syndrome compared to the general population. Previous findings also suggest that symptoms tend to decrease with age. Our primary objective is to examine whether having a close relative with fibromyalgia is associated with greater symptom severity among patients in primary care. In addition, we assess the relationship between age and symptom severity.
methodsThe study is based on a cross-sectional design. The data were collected at the Nokia Health Centre, Finland, in 2016. Patients meeting the ACR 2010 criteria were included in this study (n = 91). We used three validated questionnaires to assess disease severity (PSD, FIQ and EQ-VAS) and patient-reported information on fibromyalgia in a close relative.
resultsThe independent-samples t-test was used to examine the association. Participants were divided into four age groups, and differences in symptom severity between age groups were assessed using one-way analysis of variance (ANOVA). There were no statistically significant differences between family history and symptom severity, nor age groups and symptom severity. Furthermore, there was no statistically significant linear association between age and symptom severity, nor between symptom severity and family history of fibromyalgia. These findings remained unchanged after adjusting for family history. However, given the lack of statistical significance and our small sample size, these observations should be interpreted cautiously.
conclusionsSymptom severity and functional limitations appeared broadly similar across age groups in our sample, which may suggest that increasing age is not necessarily associated with substantial symptom relief. However, these findings should be interpreted with caution given the cross-sectional design and small sample size.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.